Physician profile
Norris D Morrison
NPI 1790098218
$3,466.67
in general payments reported to CMS, 2019-2025
33 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $674 · 2021: $999 · 2022: $402 · 2023: $468 · 2024: $339 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $562.47 | 2019-2022 | |
| Smith+Nephew, INC. | $432.90 | 2019-2025 | Collagenase Santyl, Regranex |
| Cardiovascular Systems INC. | $311.85 | 2019-2023 | Diamondback Peripheral |
| Horizon Therapeutics Plc | $275.19 | 2019-2021 | |
| Bioventus LLC | $221.18 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $213.94 | 2021-2022 | |
| Medtronic, INC. | $169.63 | 2024 | Intellis Adaptivestim |
| Angiodynamics, INC. | $149.58 | 2023 | Auryon Laser System 100-120 Vac |
| Pfizer INC. | $145.96 | 2020-2022 | |
| Organogenesis INC. | $67.89 | 2021-2023 | Puraply |
| Abbvie INC. | $63.02 | 2021-2024 | |
| Vaporox, INC. | $62.62 | 2024 | Vht-200 Wound Treatment System |
| Kci USA, INC. | $59.91 | 2021-2022 | |
| Janssen Biotech, INC. | $53.43 | 2021 | |
| Osiris Therapeutics INC. | $53.40 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $53.16 | 2019-2020 | |
| Glaxosmithkline, LLC. | $52.86 | 2020-2021 | |
| Integra Lifesciences Corporation | $52.72 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Amgen INC. | $47.49 | 2021-2025 | Krystexxa |
| Advanced Oxygen Therapy INC. | $43.78 | 2022 | |
| Paratek Pharmaceuticals, INC. | $37.31 | 2024-2025 | Nuzyra |
| Averitas Pharma INC. | $35.63 | 2025 | Qutenza |
| Allergan, INC. | $34.64 | 2019 | |
| Tactile Systems Technology INC | $34.21 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Fidia Pharma USA INC. | $33.81 | 2019 | |
| Ermi LLC | $33.79 | 2019-2020 | |
| Kerecis Limited | $32.57 | 2021-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Mallinckrodt Hospital Products INC. | $31.11 | 2022 | |
| Stryker Corporation | $25.00 | 2019 | |
| Wright Medical Technology, INC. | $24.15 | 2019 | |
| Radius Health, INC. | $21.87 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $16.48 | 2021 | |
| Merck Sharp & Dohme LLC | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norris Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.